Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.30 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.30 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16943602 | 0.82 | HSD17B10 (0.48) | USP2HTTLMNALPAR6LPAR1 | |
| SCHEMBL13484060 | 0.82 | USP2 (0.40) | USP2HTTLMNALPAR6LPAR1 | |
| SCHEMBL5697255 | 0.81 | USP2 (0.33) | USP2HTT | |
| SCHEMBL13790799 | 0.81 | USP2 (0.39) | USP2HTTLMNALPAR6LPAR1 | |
| SCHEMBL16948106 | 0.81 | HTT (0.34) | USP2HTTLMNALPAR6LPAR1 | |
| SCHEMBL10787424 | 0.81 | LMNA (0.31) | LMNALPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL13978960 | 0.79 | USP2 (0.42) | USP2HTTLMNALPAR6LPAR1 | |
| SCHEMBL430465 | 0.79 | USP2 (0.55) | USP2HTTLMNALPAR5 | |
| SCHEMBL21483327 | 0.78 | USP2 (0.32) | USP2HTT | |
| SCHEMBL13790470 | 0.78 | USP2 (0.37) | USP2HTTLPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257682-A1 | FABRIC CARE COMPOSITIONS WITH DOSE-DEPENDENT ANTIMICROBIAL ACTIVITIES THAT REDUCE THE RISK OF INFECTION AND PROMOTE HEALTH AND HYGIENE WHEN USED DISCRETELY OR SYNERGISTICALLY IN A MACHINE WASHING AND DRYING LAUNDRY PROGRAM | TJBS IP Management, LLC (US) | 2023-08-17 | — | — | US | claimed |
| US-20190142725-A1 | HAIR TREATMENT METHODS | ELC MAN LLC (US) | 2019-05-16 | — | — | US | claimed |
| EP-0363685-B1 | Fast-cure polyurethane sealant composition containing silylsubstituted guanidine accelerators | ADCO PRODUCTS INC (US) | 1994-03-23 | — | — | EP | claimed |
| EP-0459300-A2 | Fast-cure polyurethane sealant composition containing silyl-substituted guanidine accelerators | BASF Corporation (US) | 1991-12-04 | — | — | EP | claimed |
| EP-0363685-A2 | Fast-cure polyurethane sealant composition containing silylsubstituted guanidine accelerators | ADCO PRODUCTS, INC. (US) | 1990-04-18 | — | — | EP | claimed |
| US-20240199586-A1 | COMPOUND OR TAUTOMER THEREOF, COMPOSITION, LAMINATE, OPTICAL FILM, IMAGE FORMING MATERIAL, AND METHOD FOR PRODUCING COMPOUND OR TAUTOMER THEREOF | FUJIFILM CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| CN-117795017-A | Compound or tautomer thereof, composition, laminate, optical film, image forming material, and method for producing compound or tautomer thereof | 富士胶片株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-20230257682-A1 | FABRIC CARE COMPOSITIONS WITH DOSE-DEPENDENT ANTIMICROBIAL ACTIVITIES THAT REDUCE THE RISK OF INFECTION AND PROMOTE HEALTH AND HYGIENE WHEN USED DISCRETELY OR SYNERGISTICALLY IN A MACHINE WASHING AND DRYING LAUNDRY PROGRAM | TJBS IP Management, LLC (US) | 2023-08-17 | — | — | US | disclosed |
| EP-3404055-B1 | COMPOSITION, FILM, GLASS ARTICLE, COMPOUND, HIGH PURITY COMPOSITION, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING FILM | FUJIFILM CORP (JP) | 2023-08-16 | — | — | EP | disclosed |
| US-11364710-B2 | Composition, film, glass article, compound, high purity composition, method for producing compound, and method for producing film | FUJIFILM CORPORATION (JP) | 2022-06-21 | — | — | US | disclosed |
| CN-108463487-B | Composition, film, glass product, compound, high-purity composition, method for producing compound, and method for producing film | 富士胶片株式会社 | 2020-11-27 | — | — | CN | disclosed |
| EP-3404055-A1 | COMPOSITION, FILM, GLASS ARTICLE, COMPOUND, HIGH PURITY COMPOSITION, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING FILM | FUJIFILM Corporation (JP) | 2018-11-21 | — | — | EP | disclosed |
| CN-101381461-B | Crosslinkable materials based on organosilicon compounds | WACKER CHEMIE AG | 2012-10-03 | — | — | CN | disclosed |
| US-20120004364-A1 | Crosslinkable Materials Based On Organosilicon Compounds | WACKER CHEMIE AG (DE) | 2012-01-05 | — | — | US | disclosed |
| CN-101381461-A | Crosslinkable materials based on organosilicon compounds | WACKER CHEMIE AG (DE) | 2009-03-11 | — | — | CN | disclosed |
| US-20090062471-A1 | CROSSLINKABLE MATERIALS BASED ON ORGANOSILICON COMPOUNDS | WACKER CHEMIE AG (DE) | 2009-03-05 | — | — | US | disclosed |
| EP-0363685-B1 | Fast-cure polyurethane sealant composition containing silylsubstituted guanidine accelerators | ADCO PRODUCTS INC (US) | 1994-03-23 | — | — | EP | disclosed |
| EP-0459300-A2 | Fast-cure polyurethane sealant composition containing silyl-substituted guanidine accelerators | BASF Corporation (US) | 1991-12-04 | — | — | EP | disclosed |
| EP-0363685-A2 | Fast-cure polyurethane sealant composition containing silylsubstituted guanidine accelerators | ADCO PRODUCTS, INC. (US) | 1990-04-18 | — | — | EP | disclosed |
| US-4760123-A | Polyorganosiloxane, silane or hydrolyzate, curing catalyst, nitrogen containing silicon compound and polyorganosiloxane contining aminoalkyl groups | TOSHIBA SILICONE CO., LTD (JP) | 1988-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199586-A1 | COMPOUND OR TAUTOMER THEREOF, COMPOSITION, LAMINATE, OPTICAL FILM, IMAGE FORMING MATERIAL, AND METHOD FOR PRODUCING COMPOUND OR TAUTOMER THEREOF | MAPT, APP, H1-10 | USP2 3998/4885HTT 48/4885LMNA 12/4885 |
| US-11364710-B2 | Composition, film, glass article, compound, high purity composition, method for producing compound, and method for producing film | SOST, VCL, CCNO | USP2 938/4885HTT 1063/4885LMNA 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.